Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

PELNAC Bilayer Wound Matrix

K-Number: K191992 · 2020-04-29

ApplicantGunze Limited
Decision Date2020-04-29
Product CodeKGN
DecisionSubstantially Equivalent

Device Summary

PELNAC Bilayer Wound Matrix is a medical device manufactured by Gunze Limited. It received FDA 510(k) clearance on 2020-04-29 under approval number K191992. The device is classified under product code KGN. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the PELNAC Bilayer Wound Matrix?

PELNAC Bilayer Wound Matrix is a medical device that received FDA 510(k) clearance on 2020-04-29. It is manufactured by Gunze Limited. The 510(k) number is K191992.

When was PELNAC Bilayer Wound Matrix approved by the FDA?

PELNAC Bilayer Wound Matrix received FDA 510(k) clearance on 2020-04-29, under approval number K191992.

What company makes PELNAC Bilayer Wound Matrix?

PELNAC Bilayer Wound Matrix is manufactured by Gunze Limited.

What is the FDA product code for PELNAC Bilayer Wound Matrix?

The FDA product code for PELNAC Bilayer Wound Matrix is KGN.

Related Clinical Trials

Other Devices by Gunze Limited

Related Devices (Code: KGN)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.